COVID-19 ANNOUNCEMENTS are below.
The Phase One Plan for Reopening Research at OUHSC will be announced and posted on the Vice President
for Research website Monday afternoon (May 4,2020).
The OUHSC COVID-19 Return Plan has been release and is attached.
URL: https://research.ouhsc.edu/Portals/1329/Assets/Documents/HSC COVID-19 Return Plan.docx?ver=2020-05-04-095853-167
HRSA is pleased to announce the Rural Tribal COVID-19 Response program funding opportunity found here:
Through the Coronavirus Aid, Relief, and Economic Security (CARES) Act, HRSA received $15M to allocate to tribes, tribal
organizations, urban Indian health organizations, and health service providers to tribes. The funding will provide support for the
Tribes to prevent, prepare, and respond to COVID-19 in rural communities. Tribes can request up to $300K in funding for
COVID-19 related activities. For this funding opportunity, the System for Award Management (SAM) registration requirements
will be relaxed for applicants at the time of submission in Grants.gov. Current registrants in SAM, with active registrations expiring
before May 16, 2020, will be provided a one-time extension of 60 days. New applicants are able to submit an application without a
valid SAM registration. Applicants can reach out to RuralCOVIDNOFO@hrsa.gov with any questions or concerns regarding their
submission. To learn more about HRSA’s Federal Office of Rural Health Policy’s response to COVID-19, visit,
Attention Certificate of Confidentiality (CoC) Holders: Please note that if you currently have a certificate of
confidentiality for your project involving human subject research, NIH has automatically extended expiration dates.
If you have a current CoC as of April 15, 2020, it has automatically been extended for 12 months. For more information,
please click this link https://grants.nih.gov/grants/files/notice-automatic-certificate-extension-covid19.pdf.
Up to date information on allowable OUHSC research activity in response to COVID-19 can be found at:
The National Science Foundation (NSF) is accepting proposals to conduct non-medical, non-clinical-care research
that can be used immediately to explore how to model and understand the spread of COVID-19, to inform and educate
about the science of virus transmission and prevention, and to encourage the development of processes and actions to
address this global challenge.These proposals may be submitted through regular programs and/or through the RAPID
mechanism, which allows program officers to directly award up to $200,000 for projects lasting up to 24-months. These
can turn around in a matter of weeks. As an EPSCoR state, Oklahoma has a slight edge in this funding. As well, females
and members of underrepresented populations are encouraged to apply.
Fast-Grants – Fast Funding for COVID-19 Science
NIH has created a central site for its current COVID-19 guidance at
The National Human Genome Research Institute (NHGRI) issued a Notice of Special Interest (NOSI) to solicit
research proposals focused on “a better understanding of host response, associated diseases, and short- and long-term
clinical outcomes of individuals infected with SARS-CoV2.” Research interests include but are not limited to the
development of novel methods using genomic techniques to identify signatures of infection, prognosis, and severity of
disease, development of novel genomic-based tools, kits or reagents to track and monitor SARSCoV-2 infected
individuals, and use of tools to understand the genetic epidemiology of SARSCoV-2. Additional details and application
and submission details can be found in the Notice. Investigators can apply for both Administrative Supplements and
Urgent Competitive Revisions through this NOSI.
OCAST Application Review and Award Contract Management Issues Related to COVID-19
Frequently asked Questions can be found at:
Oklahoma Tobacco Settlement Endowment Trust (TSET) – Updated Guidance for Invoice Policies and
Procedures During COVID-19 Pandemic
OCAST Application Review and Award Contract Management Issues Related to COVID-19
Frequently asked Questions can be found at:
OUHSC Financial Administrators:
The federal and state governments are asking that all institutions track their expenditures related to the
COVID-19 pandemic. It is imperative that everyone is diligent in tracking all COVID-19-related expenditures for future
reimbursement opportunities. Effective immediately, all COVID-19-related expenditures incurred since March 12 should
be coded to a newly created COVID subclass. These expenditures include, but are not limited to direct COVID-19 costs,
increased housekeeping and maintenance costs, expenditures related to business process modifications, preparatory
actions, daily operations, and communications resulting from COVID-19. If COVID related expenses, since March 12,
have already been paid, please process a cost transfer using the new COVID subclass.Research faculty and staff should
also track their expenditures incurred by the shutdown of their projects and laboratories including the loss of samples,
reagents, animals and other items. Also, keep in mind that, as you resume your activities in your lab, any expenses
required to restart the lab should be coded with the COVID subclass. This will help significantly when applying for any
administrative supplements or other COVID-19 related relief efforts. Questions regarding the use of the subclass on non-
research chartfields should be forwarded to firstname.lastname@example.org and research related questions can be sent to
OUHSC Funding Requests related to COVID-19 – when submitting an item in the OUHSC SoonerTrack system
related to COVID-19 please include “COVID-19” in the title so that we are able to search on it later.
Patient-Centered Outcomes Research Institute (PCORI)
PCORI is monitoring the impact of the novel coronavirus and cases of COVID-19 to determine whether they need to alter
key dates associated with PCORI Funding Announcements (PFAs). Recognizing the challenges presented by the pandemic
and after careful consideration, they will release the Phased Large Awards for Comparative Effectiveness Research PFA on
June 9, 2020. The new deadline for required Letters of Intent will be September 29, 2020. Those invited to submit a full
application will have until January 12, 2021. These new dates correspond to PCORI’s Cycle 3 2020 timeline. Please feel
free to share this information with anyone who may be interested.
Department of Defense – Supplemental Guidance on Administrative Flexibilities for Grants and
Cooperative Agreements in Response to COVID-19 Pandemic
COVID-19/Coronavirus Resources – a list from InfoEd
Notice of Special Interest (NOSI) Regarding the Availability of Urgent Competitive Revisions for
Research on Coronavirus Disease 2019 (COV-19) and the Causative Virus SARS-CoV-2 (NOT-GM-20025)
DONATION OF TESTING SUPPLIES
OU Physicians has requested that researchers look into their supplies and see whether they can donate any of the Testing
supplies listed in the attached “Testing Donations”. Please return the complete form to Kristen.Namey@oumedicine.com.
URL: https://research.ouhsc.edu/Portals/1329/Assets/Documents/Testing Donations.xlsx?ver=2020-03-23-093320-937
DONATION OF PPE SUPPLIES
OU Physicians has requested that researchers look into their supplies and see whether they can donate any of the PPE
supplies listed in the attached “research PPE donation”. The first line is an example of how to fill out the form.
Please return completed form to Erin-Bailey@ouhsc.edu.
URL: https://research.ouhsc.edu/Portals/1329/Assets/Documents/Copy of research PPE donation.xlsx?ver=2020-03-23-093320-780
OUHSC Colleagues: Attached is a memo from The Jackson Laboratory to assist researchers with preserving
valuable lines which might be lost during the pandemic situation, and for which may not be in their existing 11,000 line storage
locker for researcher access. The OUHSC Department of Comparative Medicine can assist with animal preparation for ship
out of your line(s). URL: https://research.ouhsc.edu/Portals/1329/Assets/Documents/JAXLabs_04202020.docx?ver=2020-04-13-115833-513
REQUEST FOR LETTERS OF INTENT- BRAIN RESEARCH FOUNDATION/SCIENTIFIC INNOVATIONS AWARD
The University of Oklahoma Health Sciences Center is seeking Letters of Intent (LOI) from Associate or Full Professors for the
Scientific Innovation Award (SIA) sponsored by the Brain Research Foundation (BRF). The LOI will be due May 22, 2020 to the
Vice-President for Research (VPR@OUHSC.edu) and only one LOI will be selected for submission to the Brain Research
Foundation. The BRF provides funding for innovative science in both basic and clinical neuroscience. The objective of the SIA
is to support projects that may be too innovative and speculative for traditional funding sources but still have a high likelihood
of producing important findings. It is expected that investigations supported by these grants will yield high impact findings and
result in major grant applications and significant publications in high impact journals. The SIA award is limited to $150,000
(total direct costs) for a two year grant period. Only one PI may apply per application (multi-PI grants are not allowed).
Please see the attachment BRF Request for Applications for full details.
URL: https://research.ouhsc.edu/Portals/1329/Assets/Documents/BRF_REQUEST FOR APPLICATIONS.pdf?ver=2020-05-04-095853-197
Kidney Cancer Association (KCA) annual grant program for clinicians and scientists doing innovative research in
kidney cancer. The KCA supports two types of grants:
- Advanced Discovery Awards (two awards, $500,000 each)
- Young Investigator Awards (four awards, $75,000 each)
Applications are open now. Deadline for both programs is August 5, 2020. Linked below are the press release and the grants
information and submission page.
Press release: https://www.kidneycancer.org/the-kidney-cancer-association-seeks-applicants-for-1-3-million-in-grant-funding/
Information and submission page: https://kidneycancer.submittable.com/submit
National Institutes of Health (NIH) - This message is a reminder that grant applicants must use FORMS-F for all
application due dates on or after May 25, 2020. ASSIST has been updated to support the new application forms
(FORMS-F) and eRA is ready to process those applications submitted using FORMS-F.
2021 Pew Scholars Program in Biomedical Sciences Award – Deadline 5pm, Tuesday, May 5, 2020
OUHSC is soliciting nominees for the 2021 Pew Scholars Program in Biomedical Sciences award. A single nominee will be
selected from OUHSC and forwarded to the Pew Foundation for the next level of review. To be considered eligible,
applicants must have a doctorate in biomedical sciences or medicine and must be an assistant professor (modified title
appointments are ineligible) and must have been appointed after June 14th, 2017. Nominees selected by the Pew
Foundation will receive $75,000 in support for four years ($300,000 total). Candidates interested in this program should
submit a two-page research project summary, curriculum vitae, and letter of support from their department chair via email
to VPR@ouhsc.edu. The deadline for submission is 5:00 PM, May 5th, 2020. The individual selected as the OUHSC
nominee will be notified on or before May 18th, 2020.
The 2020 BeHEARD (Helping Empower and Accelerate Research Discoveries) Challenge is hosted annually
by the Rare Genomics Institute and is open globally to researchers, foundations, or anyone whose research is constrained
due to limited resources. This year, we have over $85,000 of technologies available for researchers. They collaborate with
companies to provide free technology grants including mouse models, genome analysis software, antibodies and plasmids.
Applicants select one or more technologies that they think would benefit their research, and submit a proposal for each
technology. Research proposals are evaluated based on the technology's fit with the research and the potential for the
research to advance rare disease treatments. The application is short (~2 pages) and very straightforward. For more
information on the competition and the application, please visit our website: http://www.raregenomics.org/beheard-competition/.
The deadline for applications is May 31, 2020.
Oklahoma Medical Research Foundation – Expanding Excellence in Developmental Biology in Oklahoma CoBRE
Pilot Projects – Deadline May 31, 2020. See attached document for additional information.
URL: https://research.ouhsc.edu/Portals/1329/Assets/Documents/OMRF_Call for COBRE Pilot Project Proposals.pdf?ver=2020-02-17-074940-847
The Oklahoma Center for Microbial Pathogenesis and Immunity COBRE – Pilot Project Awards Deadline extended
to May 15, 2020. For additional information see the attached document.
URL: https://research.ouhsc.edu/Portals/1329/Assets/Documents/Micro_COBRE Pilot RFA 032320.pdf?ver=2020-03-29-114558-020
Attention: OUHSC FY20 State Contract Budget Planning
F&A (IDC) are real costs incurred by the department and the University in support of sponsored activities. The funding derived
from F&A provides critical dollars necessary to support the operating expenses related to the space in which the project is
conducted, as well as the various services provided to the Principal Investigator and the college and department for
administering the contract (e.g., accounting, purchasing, human resources). Without appropriate recovery of F&A costs, the
University loses money and we must be fiscally responsible to our tax payers and students. It is not responsible stewardship
to waive these costs. Since this is the time of year when a lot of departments and faculty start their FY21 budget planning for
their anticipated state contracts, we wanted to remind everyone that no F&A reduction or waiver requests will be approved this
year. As always, Please see this link for current F&A rates:
To review OUHSC Facilities and Administration Policy for Externally Funded Projects, please see this link:
Frequently Asked Questions for NOT-AG-20-022 Notice of Special Interest (NOSI): NIA Availability of Administrative
Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)
Pre-Application Webinar for RFA-CA-20-031, Strengthening Institutional Capacity to Conduct Global Cancer Research in
Low- and Middle-Income Countries (D43 Clinical Trial Not Allowed)
Notice of Eligibility Change for NIDCD Urgent Competitive Revisions and Administrative Supplements for Research on
Notice of NCATS Withdrawal from Participation in PAR-18-690, Innovative Therapies and Tools for Screenable Disorders
in Newborns (R03 Clinical Trial Optional) (NOT-TR-20-023)
Notice of NCATS Withdrawal from Participation in PAR-18-689, Innovative Therapies and Tools for Screenable Disorders
in Newborns (R01 - Clinical Trial Optional) (NOT-TR-20-024)
Notice of Special Interest (NOSI): Cannabis, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older
Notice of Special Interest (NOSI): Availability of Administrative Supplements to Diversify the NIDDK Clinical Trial Workforce
Notice of Special Interest (NOSI): Availability of Administrative Supplements to NIDDK STEP-UP Centers for Increased
Notice of Special Interest: Administrative Supplements for Research on Ethical, Legal and Social Issues regarding
Post-mortem Pediatric Tissue Procurement for Research Purposes (Admin Supp Clinical Trial Optional) (NOT-HD-20-012)
HEAL Initiative: Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements to Support
Strategies to Reduce Stigma in Pain Management and Opioid Use Disorder (OUD) and Treatment (NOT-OD-20-101)
Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions and Administrative Supplements to
Clinical and Translational Science Award (CTSA) Program Awards to Address 2019 Novel Coronavirus Disease
(COVID-19) Public Health Needs (NOT-TR-20-028)
Please Note: When only one application is allowed per Institution according to the sponsor
instructions, a one-page letter of intent summarizing the proposed project should be submitted
to the Vice President for Research at least two months prior to the application deadline (unless
otherwise noted). The letters of intent will be reviewed and a single application will be chosen
for submission from the University.
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)
(PA-20-166) – Deadline dates vary by awarding IC. Applicants are encouraged to apply early to allow adequate time
to make any corrections to errors found in the application during the submission process by the due date.
Independent Scientist Award (Parent K02 - Independent Clinical Trial Required) (PA-20-171)
Deadline June 12, 2020 and October 12, 2020
Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial
Optional) (PA-20-172) - Deadline October 5, 2020
Independent Scientist Award (Parent K02 Independent Basic Experimental Studies with Humans Required)
(PA-20-173) – Deadline June 12, 2020 and October 12, 2020
Independent Scientist Award (Parent K02 - Independent Clinical Trial Not Allowed) (PA-20-174)
Deadline June 12, 2020 and October 12, 2020
IDeA Program Infrastructure for Clinical and Translational Research (IDeA-CTR)(U54 - Clinical Trial Optional)
(PAR-20-175) - Deadline October 7, 2020 and October 7, 2021
Mucosal Immunology Studies Team (MIST) (U01 Clinical Trial Not Allowed). (RFA-AI-20-027)
Deadline October 9, 2020
Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases
(R03 Clinical Trial Not Allowed) (RFA-RM-20-019) – Deadline July 15, 2020
District Attorney Council – 2020 Coronavirus Emergency Supplemental Funding Grant – Currently no Deadline
Oklahoma Center for Adult Stem Cell Research (OCASCR) – Grant Deadline is September 15, 2020